Neptune to Hold Conference Call to Discuss Fourth Quarter

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year Results

LAVAL, Quebec, May 7, 2015 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq: NEPT ) (TSX: NTB ), announced today that it will be holding a conference call on Thursday May 28, 2015 at 9:00 AM (ET) to discuss its results for the fourth quarter and fiscal year ended February 28, 2015.

The fourth quarter and fiscal year results press release will be issued after markets close on May 27, 2015.

Conference Call Details:

Date: Thursday May 28, 2015
Time: 9:00 AM Eastern Time
Conference ID: 42232164
Call: 1‐877-380-5664 (within Canada & the U.S.)
  1-631-813-4882 (Outside Canada and the U.S.)
  (Please dial in 15 minutes before the call begins) 
   
Webcast: A live audio webcast can be accessed at:
   http://neptunekrilloil.com/investors/investor-events-and-presentations/

An archived recording of the conference call will also be available on Neptune's website shortly after the call.

About Neptune Technologies & Bioressources Inc.

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (''PUFAs''). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune's products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune's head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec.

Through its subsidiary Acasti Pharma Inc. ("Acasti"), in which Neptune holds approximately 48% of the participating and voting rights, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti focuses on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases. Its lead prescription drug candidate is CaPre ® , a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.

Forward Looking Statements

Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. securities laws and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties,   readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Neptune's latest Annual Information Form, which also forms part of Neptune's latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com , on EDGAR at www.sec.gov/edgar.shtml and on the investor section of Neptune's website at www.neptunebiotech.com (the "AIF"). All forward-looking statements in this press release are made as of the date of this press release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in Neptune public securities filings with the Securities and Exchange Commission and the Canadian securities commissions. Additional information about these assumptions and risks and uncertainties is contained in the AIF under "Risk Factors".

Neither NASDAQ nor the Toronto Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

Neptune Contacts: John Ripplinger Investor Relations +1.450.687.2262 neptunebiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 104

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 105

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 55

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 66

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 340

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 87

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 197

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading

Top 5 Most Recently Viewed Articles

Ringkjøbing Landbobank's Impressive Mid-Year Financial Update

Updated Category News Views 214

Ringkjøbing Landbobank's Financial Performance for 2025 In an exciting turn of events, Ringkjøbing Landbobank has shared its quarterly report for the first half of 2025, revealing remarkable financial outcomes that have caught the attention of analysts and stakeholders alike. Approval from Management The bank's board of directors, along with its general management, has...

Continue Reading
Mercy Medical Opens Center for Orthopedic Innovation

Updated Category News Views 42

Foot and Ankle Care Leap at Mercy Medical Mercy Medical Center in Baltimore is shaking things up in the orthopedic world. On August 10, 2026, they pulled the curtain back on the Center for Orthopedic Innovation, a place where the future of foot and ankle care is being molded. Led by renowned figure Dr. Lew Schon, they've crafted a cutting-edge space that’s all about...

Continue Reading
GECU's $4.9B Milestone: Navigating Regulatory Hurdles

Updated Category News Views 49

GECU's Bold Step: Merging with Bank of the Southwest When the gears of the financial world start grinding, there's no room for hesitation. GECU, one of the powerhouses when it comes to credit unions locally in Texas and New Mexico, has just snagged the regulatory green light to merge with the Bank of the Southwest. Talk about making moves—this transition's poised to...

Continue Reading
Taiwan's Economic Surge Driven by AI Innovations and Exports

Updated Category News Views 264

Economic Growth Outlook in Taiwan Taiwan has recently upgraded its economic growth forecast, reflecting its robust performance amid the ongoing AI revolution. As global appetite for AI-driven technology continues to surge, Taiwan is poised to reap substantial benefits. AI-Driven Exports In a remarkable display of economic resilience, Taiwan's exports skyrocketed almost...

Continue Reading
Exceptional Gold Intersections Reported at Keats Trench

Updated Category News Views 111

Major Discoveries in Gold Exploration New Found Gold Corp. (TSXV: NFG) (NYSE-A: NFGC) is thrilled to disclose impressive results from the second phase of channel sampling at Keats Trench as part of its ongoing exploration efforts at the Queensway Project. Highlights from Keats Trench Phase II The company noted exceptional intercepts in its sampling campaign, including...

Continue Reading